Imperial College London
Imperial College London is currently ranked 3rd best University in Europe and 10th in the world, while our Engineering and Technology research fields are ranked 4th in Europe and 9th in the world according to the Times Higher Education World University Rankings 2013-2014. The NANOMED team from Imperial is led by Prof. Molly Stevens, currently Professor of Biomedical Materials and Regenerative Medicine and the Research Director for Biomedical Material Sciences in the Department of Materials, Department of Bioengineering and the Institute of Biomedical Engineering. The Stevens Group is an extremely multidisciplinary research program focusing on the development of bio-inspired materials, including innovative tissue engineering approaches in regenerative medicine, nanomaterials-based systems as disease diagnostic devices and materials-based characterization approaches that reveal information on the cell-material interface. The Stevens Group comprises engineers, chemists, cell biologists and surgeons that occupy labs focused on the development of biomaterials for regenerative medicine and biosensing. The labs host a broad array of equipment for synthesis/materials fabrication (e.g. peptide synthesizer and electrospinner), biological characterisation (e.g. FACS, ELISA and PCR), material characterization equipment (e.g. mechanical testers and AFM), which will all be instrumental for the completion of this proposed project. The lab users also have use of informative materials-based techniques, such as Raman micro-spectroscopy housed in the newly refurbished high-content imaging facility, as well as multiple microscopic imaging techniques available from the Harvey Flower Microstructural Characterisation Suite, such as SEM and TEM.